Raymond James Financial Services Advisors’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,773
Closed -$578K 3404
2023
Q1
$578K Sell
4,773
-17
-0.4% -$1.96K ﹤0.01% 2244
2022
Q4
$550K Buy
4,790
+44
+0.9% +$4.85K ﹤0.01% 2213
2022
Q3
$480K Hold
4,746
﹤0.01% 2273
2022
Q2
$481K Buy
4,746
+166
+4% +$18.1K ﹤0.01% 2303
2022
Q1
$533K Buy
4,580
+338
+8% +$39.1K ﹤0.01% 2344
2021
Q4
$486K Buy
+4,242
New +$484K ﹤0.01% 2384

Other funds holding BSX.PRA

Raymond James Financial Services Advisors's BSX.PRA Position: Q2 2023 in Review

Raymond James Financial Services Advisors sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 4,773 shares — an estimated $578K sold.

Raymond James Financial Services Advisors first reported a position in BSX.PRA in Q4 2021 and held it in 6 quarters. The position peaked at $578K in Q1 2023. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

  • Raymond James Financial Services Advisors reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 4,773 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $578K.
  • Raymond James Financial Services Advisors first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q4 2021 and held it in 6 quarters.
  • Raymond James Financial Services Advisors's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $578K in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2023, filed 25 Jul 2023.